SCHEMBL18509896

SCHEMBL18509896

Cn1cc(CCC(=O)O)c2ccc(C3CC3)cc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 1/20 0.45
PLA2G10 O15496 1/20 0.42
PLA2G2A P14555 1/20 0.42
PPARG P37231 2/20 0.41
PPARD Q03181 2/20 0.41
PPARA Q07869 2/20 0.41
NR1D1 P20393 1/20 0.41
GRM2 Q14416 1/20 0.40
GRM3 Q14832 1/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
CMA1 P23946 1/20 0.39
HSD17B10 Q99714 3/20 0.39
USP2 O75604 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TP53 P04637 2/20 0.38
KDM4E B2RXH2 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19872775 0.90 FABP4 (0.50) FABP4PLA2G10PLA2G2APPARGPPARD
SCHEMBL15322731 0.80 SPR (0.47) PPARGPPARDPPARAKMT2AMEN1
SCHEMBL20119861 0.80 CDK2 (0.51) KMT2AMEN1CMA1HSD17B10TP53
SCHEMBL18029041 0.79 MAPT (0.47) FABP4NR1D1GRM2GRM3KMT2A
SCHEMBL23226415 0.79 MCL1 (0.53) KMT2AMEN1CMA1
SCHEMBL19872707 0.79 HPGD (0.48) PPARGPPARDPPARAGRM2GRM3
SCHEMBL20935020 0.79 CDK2 (0.52) KMT2AMEN1CMA1HSD17B10TP53
SCHEMBL23226315 0.77 KMT2A (0.42) PPARGPPARDPPARAKMT2AMEN1
SCHEMBL21392039 0.77 FABP4 (0.45) FABP4PLA2G10PLA2G2AHSD17B10KDM4E
SCHEMBL15167291 0.77 ACMSD (0.44) FABP4KMT2AMEN1LMNAMAT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10550079-B2 Artificial self-sufficient cytochrome P450s UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2020-02-04 US disclosed
US-20190119208-A1 ARTIFICIAL SELF-SUFFICIENT CYTOCHROME P450S UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2019-04-25 US disclosed
WO-2016134145-A9 ARTIFICIAL SELF-SUFFICIENT CYTOCHROME P450S UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2017-02-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10550079-B2 Artificial self-sufficient cytochrome P450s CYP4F2, CYP2F1, POR FABP4 2005/4885PLA2G10 1089/4885PLA2G2A 1346/4885
US-20190119208-A1 ARTIFICIAL SELF-SUFFICIENT CYTOCHROME P450S CYP4F2, CYP2F1, POR FABP4 2005/4885PLA2G10 1089/4885PLA2G2A 1346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.